Isolator Technology for Aseptic Filling of High Potent Products - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Isolator Technology for Aseptic Filling of High Potent Products

PIERRE FABRE MEDICAMENT PRODUCTION owns a manufacturing site in the south of France, which has some of the largest experience worldwide with 22 years usage of isolator technology for aseptic filling of high potent freeze-dried injectable products.

Its newest generation of cytotoxic suites were built a few years ago to manufacture new products in compliance with worldwide CGMP and European ATEX regulation. All process operations: dispensing, compounding, filling, lyophilization, capping and external decontamination of the vial, are done under isolator technology. PFMP has developed an innovative filling line with Washing In Place system and Sterilization In Place system of the isolators with built-in Vaporized Hydrogen Peroxyde generator. These two new suites were granted “Most Advanced Facility of the Year” by European Outsourcing Awards in 2008.

PFMP proposes to its partners a full CDMO service with full Development of Product and Active Ingredient, Contract Manufacturing of API and Finish Product including freeze-drying cycle development. Its main objective is always to offer process technology innovation to manufacture future products and to guaranty the compliance with the evolution of the Quality criteria as well as the Environmental and Safety conditions.

Contact: Franck PAVAN, Outsourcing & Business Development Manager


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here